Galmed Pharmaceuticals (GLMD) Long-Term Investments (2022 - 2025)

Galmed Pharmaceuticals' Long-Term Investments history runs 4 years deep, the most recent figure standing at $30000.0 for Q4 2025.

• In Q4 2025, Long-Term Investments rose 11.11% year-over-year to $30000.0; the TTM figure through Dec 2025 stood at $30000.0 (up 11.11% YoY), while the FY2025 annual figure was $30000.0, up 11.11% from the prior year.
• Long-Term Investments for Q4 2025 stood at $30000.0, down from $1.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $3.3 million in Q2 2023, with the low at $27000.0 in Q4 2024.
• The 4-year median for Long-Term Investments is $2.7 million (2023), against an average of $2.2 million.
• The sharpest annual moves came in 2023 and 2024: Long-Term Investments soared 117.67% in 2023, then plunged 99.17% in 2024.
• Galmed Pharmaceuticals' Long-Term Investments stood at $1.5 million in 2022, then jumped by 117.67% to $3.3 million in 2023, then slumped by 99.17% to $27000.0 in 2024, then rose by 11.11% to $30000.0 in 2025.
• Business Quant data shows GLMD's Long-Term Investments at $30000.0 in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.